糖皮质激素和免疫抑制剂治疗溃疡性结肠炎的安全性

]William R. Connell MD, FRACP (Consultant Gastroenterologist), Andrew C.F. Taylor MBBS (gastroenterology Registrar)
{"title":"糖皮质激素和免疫抑制剂治疗溃疡性结肠炎的安全性","authors":"]William R. Connell MD, FRACP (Consultant Gastroenterologist),&nbsp;Andrew C.F. Taylor MBBS (gastroenterology Registrar)","doi":"10.1016/S0950-3528(97)90057-9","DOIUrl":null,"url":null,"abstract":"<div><p>For many years, corticosteroids have been the mainstay for treating acute ulcerative colitis. In patients with refractory disease, immunosuppressive therapy may be indicated, including azathioprine or its metabolite 6-mercaptopurine, cyclosporin and possibly methotrexate. Their benefits in ulcerative colitis must be weighed up against their possible adverse effects, the availability of surgical cure for this condition, and the long-term risk of carcinoma complicating colitis that applies in patients with chronic extensive disease. Information about the safety of corticosteroids and immunosuppressive agents has accumulated as a result of their extensive use in inflammatory bowel disease, organ transplantation and various other disorders.</p></div>","PeriodicalId":77028,"journal":{"name":"Bailliere's clinical gastroenterology","volume":"11 1","pages":"Pages 111-128"},"PeriodicalIF":0.0000,"publicationDate":"1997-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0950-3528(97)90057-9","citationCount":"2","resultStr":"{\"title\":\"8 Safety of corticosteroids and immunosuppressive agents in ulcerative colitis\",\"authors\":\"]William R. Connell MD, FRACP (Consultant Gastroenterologist),&nbsp;Andrew C.F. Taylor MBBS (gastroenterology Registrar)\",\"doi\":\"10.1016/S0950-3528(97)90057-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>For many years, corticosteroids have been the mainstay for treating acute ulcerative colitis. In patients with refractory disease, immunosuppressive therapy may be indicated, including azathioprine or its metabolite 6-mercaptopurine, cyclosporin and possibly methotrexate. Their benefits in ulcerative colitis must be weighed up against their possible adverse effects, the availability of surgical cure for this condition, and the long-term risk of carcinoma complicating colitis that applies in patients with chronic extensive disease. Information about the safety of corticosteroids and immunosuppressive agents has accumulated as a result of their extensive use in inflammatory bowel disease, organ transplantation and various other disorders.</p></div>\",\"PeriodicalId\":77028,\"journal\":{\"name\":\"Bailliere's clinical gastroenterology\",\"volume\":\"11 1\",\"pages\":\"Pages 111-128\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1997-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0950-3528(97)90057-9\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bailliere's clinical gastroenterology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0950352897900579\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bailliere's clinical gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0950352897900579","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

多年来,皮质类固醇一直是治疗急性溃疡性结肠炎的主要药物。对于难治性疾病的患者,可能需要免疫抑制治疗,包括硫唑嘌呤或其代谢物6-巯基嘌呤、环孢素和可能的甲氨蝶呤。它们对溃疡性结肠炎的益处必须与它们可能的副作用、手术治疗的可得性以及慢性广泛疾病患者发生癌性结肠炎的长期风险进行权衡。由于皮质类固醇和免疫抑制剂在炎症性肠病、器官移植和各种其他疾病中的广泛应用,有关其安全性的信息已经积累起来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
8 Safety of corticosteroids and immunosuppressive agents in ulcerative colitis

For many years, corticosteroids have been the mainstay for treating acute ulcerative colitis. In patients with refractory disease, immunosuppressive therapy may be indicated, including azathioprine or its metabolite 6-mercaptopurine, cyclosporin and possibly methotrexate. Their benefits in ulcerative colitis must be weighed up against their possible adverse effects, the availability of surgical cure for this condition, and the long-term risk of carcinoma complicating colitis that applies in patients with chronic extensive disease. Information about the safety of corticosteroids and immunosuppressive agents has accumulated as a result of their extensive use in inflammatory bowel disease, organ transplantation and various other disorders.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信